May 11, 2018 - BioDelivery Sciences' (BDSI) reports narrower-than-expected loss in Q1. Sales marginally beat the consensus mark.
May 11, 2018 - AGN grew Q1 2018 revenue by 3% Y/Y. Organic growth was practically nil. LOE for U.S. General Medicine has started to materialize. If generic Restasis finally arrives it could amplify AGN's pain. With
May 10, 2018 - Wall Street Rallies on Thursday, Stocks: ROKU,CTL,XRAY,AGN,MYL,ALB,M,KSS,GPS, release date:May 10, 2018
May 10, 2018 - SVA Plumb Wealth Management, LLC Buys Walt Disney Co, General Electric Co, Allergan PLC, Sells WisdomTree U.S. MidCap Dividend Fund, iShares 7-10 Year Treasury Bond ETF, WisdomTree U.S. SmallCap Dividend Fund, Stocks: DIS,GE,SLB,VBR,BSV,VYM,AGN,BNDX,IDV,CELG,GILD,SNY,, release date:May 10, 2018
May 09, 2018 - Tom Gayner Sells Monsanto, Moody, Stocks: MON,MCO,FDS,PCAR,PDCO,AGN,BG, release date:May 09, 2018
May 09, 2018 - Aerie (AERI) reported a narrower-than-expected loss in the first quarter. The launch of the lead drug Rhopressa is underway.
May 08, 2018 - Takeda Closes In on Shire, but It's Not a Done Deal Yet, Stocks: SHPG,AGN,TSE:4502,XSWX:RO, release date:May 08, 2018
May 08, 2018 - Wunderlich Capital Managemnt Buys GlaxoSmithKline PLC, Alibaba Group Holding, Allergan PLC, Sells Colgate-Palmolive Co, Thomson Reuters Corp, iShares MSCI Emerging Index Fund, Stocks: SYY,IEF,GSK,BABA,AGN,MDLZ,DWDP,CL,TRI,EEM,EWI,EWP,, release date:May 08, 2018
May 08, 2018 - Volatility remaining elevated due to the restasis situation.It is affecting the share price.Investors should look at other growth areas such as CoolSculpting. Eventually this stock will bottom.
May 08, 2018 - Investor focus will be on the performance of BioDelivery Sciences' (BDSI) two marketed drugs, Belbuca (chronic pain) and Bunavail (opioid-dependence).